サマリー

主な調査結果
世界の創薬市場は、予測期間である2022年から2030年の間にCAGR6.58%を記録すると予測されています。複数の疾患治療のための研究開発努力の増加と技術の進歩が、市場成長を推進する主な要因となっています。
市場に関する考察
創薬には、薬理学、化学、生物学などの幅広い科学分野において、新薬の可能性を特定することが含まれます。創薬プロセスの状況は、医薬品開発のための革新的な方法と技術によって激変しています。これにより、研究機関や製薬会社は、さまざまな病気や健康状態に対する解決策や治療法を見出すことができるようになりました。さらに、企業はナノテクノロジー、バイオチップ、自動化プロセス、クラウドコンピューティング、人工知能を導入しています。
一方で、新薬の発見と開発には、予備研究から市場への導入まで、ほぼ10～15年の歳月を要します。また、どの開発段階においても、考慮すべきリスクが存在します。
地域的には、欧州と北米の国々が数十年にわたり創薬に秀でていますが、これは主に啓発プログラム、政府およびCROの取り組み、製薬会社などに起因するものです。市場成長の阻害要因としては、プロジェクトの実現可能性と成功率、高度に規制された市場、時間のかかるプロセスなどが挙げられます。
地域別インサイト
世界の創薬市場の成長分析には、北米、欧州、アジア太平洋地域、その他の地域の地理的評価が含まれています。北米は最も高い収益シェアに関して主要な地域であり、主に様々な技術の進歩に起因しています。
競合の洞察
激しい競争は、新規参入企業間の提携、パートナーシップ、ファンドプロジェクトによるものです。市場の主要企業には、Roche AG、Eli Lilly and Company、Johnson & Johnson、Novartis AGなどが挙げられます。
当社のレポート提供内容は以下の通りです。
- 市場全体に関する主要な知見の調査
- 市場力学（推進要因、抑制要因、機会、課題）の戦略的な内訳
- 全セグメント、サブセグメント、地域の3年分の過去データとともに、最低9年間の市場予測を掲載
- 市場細分化により、主要セグメントを徹底的に評価し、その市場推定値を提示
- 地域別分析。言及された地域および国別セグメントの評価とその市場占有率
- 主要な分析ポーターの5つの力分析、ベンダーランドスケープ、オポチュニティマトリックス、キーバイヤークライテリア、など。
- コンペティティブ・ランドスケープは、主要企業を要因や市場シェアなどに基づいて理論的に説明したものです。
- 企業プロファイリング。詳細な企業概要、提供する製品/サービス、SCOT分析、最近の戦略的展開など

ページTOPに戻る

目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING R&D FOR TACKLING SEVERAL DISEASES
3.1.2. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. EXTENSIVE TIME-CONSUMING PROCESS
3.2.2. HIGHLY REGULATED MARKET
3.2.3. PROJECT FEASIBILITY AND SUCCESS RATE
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON GLOBAL DRUG DISCOVERY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. DRUG DISCOVERY AND DEVELOPMENT PROCESS
4.5.1. DRUG DISCOVERY AND DEVELOPMENT
4.5.2. PRECLINICAL RESEARCH
4.5.3. CLINICAL RESEARCH
4.5.4. REGULATORY AUTHORITY REVIEW
4.5.5. POST MARKET SAFETY MONITORING
4.6. REGULATORY FRAMEWORK
5. MARKET BY DRUG TYPE
5.1. SMALL MOLECULE DRUG
5.2. BIOLOGIC DRUG
6. MARKET BY SERVICE
6.1. CHEMICAL SERVICES
6.2. DRUG METABOLISM AND PHARMACOKINETICS SERVICES
6.3. BIOLOGICAL SERVICES
6.4. OTHER PHARMACEUTICAL SERVICES
7. MARKET BY END-USERS
7.1. PHARMACEUTICAL COMPANIES
7.2. CONTRACT RESEARCH ORGANIZATIONS
7.3. RESEARCH INSTITUTES
7.4. OTHER END-USERS
8. MARKET BY TECHNOLOGY
8.1. HIGH THROUGHPUT SCREENING
8.2. SPECTROSCOPY
8.3. COMBINATORIAL CHEMISTRY
8.4. BIOCHIPS
8.5. PHARMACOGENOMICS AND PHARMACOGENETICS
8.6. BIOINFORMATICS
8.7. METABOLOMICS
8.8. NANOTECHNOLOGY
8.9. OTHER TECHNOLOGIES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY GROWTH ENABLERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.2. CANADA
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. KEY GROWTH ENABLERS
9.2.3. KEY CHALLENGES
9.2.4. KEY PLAYERS
9.2.5. COUNTRY ANALYSIS
9.2.5.1. UNITED KINGDOM
9.2.5.2. GERMANY
9.2.5.3. FRANCE
9.2.5.4. ITALY
9.2.5.5. RUSSIA
9.2.5.6. SPAIN
9.2.5.7. SCANDINAVIA
9.2.5.8. REST OF EUROPE
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. KEY GROWTH ENABLERS
9.3.3. KEY CHALLENGES
9.3.4. KEY PLAYERS
9.3.5. COUNTRY ANALYSIS
9.3.5.1. CHINA
9.3.5.2. JAPAN
9.3.5.3. INDIA
9.3.5.4. SOUTH KOREA
9.3.5.5. INDONESIA
9.3.5.6. SINGAPORE
9.3.5.7. TAIWAN
9.3.5.8. AUSTRALIA & NEW ZEALAND
9.3.5.9. REST OF ASIA-PACIFIC
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. KEY GROWTH ENABLERS
9.4.3. KEY CHALLENGES
9.4.4. KEY PLAYERS
9.4.5. REGIONAL ANALYSIS
9.4.5.1. LATIN AMERICA
9.4.5.2. MIDDLE EAST & AFRICA
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. AGILENT TECHNOLOGIES INC
10.2.2. ASTRAZENECA PLC
10.2.3. BAYER AG
10.2.4. CHARLES RIVER LABORATORIES INTERNATIONAL INC
10.2.5. ELI LILLY AND COMPANY
10.2.6. EVOTEC SE
10.2.7. GLAXOSMITHKLINE PLC
10.2.8. ICON PLC
10.2.9. IQVIA HOLDINGS INC
10.2.10. JOHNSON & JOHNSON
10.2.11. MERCK & CO INC
10.2.12. NOVARTIS AG
10.2.13. PFIZER INC
10.2.14. ROCHE AG



LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - GLOBAL DRUG DISCOVERY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL BIOLOGIC DRUG MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL BIOLOGIC DRUG MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL CHEMICAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL CHEMICAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL DRUG METABOLISM AND PHARMACOKINETICS SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL DRUG METABOLISM AND PHARMACOKINETICS SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL DRUG DISCOVERY MARKET, BY END-USERS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL DRUG DISCOVERY MARKET, BY END-USERS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: GLOBAL SPECTROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: GLOBAL SPECTROSCOPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 36: GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 37: GLOBAL BIOCHIPS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 38: GLOBAL BIOCHIPS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 39: GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 40: GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 41: GLOBAL BIOINFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 42: GLOBAL BIOINFORMATICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 43: GLOBAL METABOLOMICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 44: GLOBAL METABOLOMICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 45: GLOBAL NANOTECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 46: GLOBAL NANOTECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 47: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 48: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 49: GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 50: GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 51: NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 52: NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 53: LEADING PLAYERS OPERATING IN NORTH AMERICA DRUG DISCOVERY MARKET
TABLE 54: EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 55: EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 56: LEADING PLAYERS OPERATING IN EUROPE DRUG DISCOVERY MARKET
TABLE 57: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 58: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 59: LEADING PLAYERS OPERATING IN ASIA-PACIFIC DRUG DISCOVERY MARKET
TABLE 60: REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 61: REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 62: LEADING PLAYERS OPERATING IN REST OF WORLD DRUG DISCOVERY MARKET
TABLE 63: LIST OF MERGERS & ACQUISITIONS
TABLE 64: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 66: LIST OF BUSINESS EXPANSIONS & DIVESTITURES




LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: DRUG DISCOVERY AND DEVELOPMENT PROCESS
FIGURE 5: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY DRUG TYPE, IN 2021
FIGURE 6: GLOBAL DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2022-2030 (IN $ MILLION)
FIGURE 7: GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2022-2030 (IN $ MILLION)
FIGURE 8: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 9: GLOBAL DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 12: GLOBAL DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY END-USERS, IN 2021
FIGURE 14: GLOBAL DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)
FIGURE 16: GLOBAL DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2022-2030 (IN $ MILLION)
FIGURE 17: GLOBAL DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
FIGURE 18: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 19: GLOBAL DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2022-2030 (IN $ MILLION)
FIGURE 20: GLOBAL DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
FIGURE 21: GLOBAL DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2022-2030 (IN $ MILLION)
FIGURE 22: GLOBAL DRUG DISCOVERY MARKET, BY BIOCHIPS, 2022-2030 (IN $ MILLION)
FIGURE 23: GLOBAL DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2022-2030 (IN $ MILLION)
FIGURE 24: GLOBAL DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2022-2030 (IN $ MILLION)
FIGURE 25: GLOBAL DRUG DISCOVERY MARKET, BY METABOLOMICS, 2022-2030 (IN $ MILLION)
FIGURE 26: GLOBAL DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2022-2030 (IN $ MILLION)
FIGURE 27: GLOBAL DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2022-2030 (IN $ MILLION)
FIGURE 28: NORTH AMERICA DRUG DISCOVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 29: UNITED STATES DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: CANADA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: EUROPE DRUG DISCOVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 32: UNITED KINGDOM DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: GERMANY DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: FRANCE DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: ITALY DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: RUSSIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: SPAIN DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: SCANDINAVIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC DRUG DISCOVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 41: CHINA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: JAPAN DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SOUTH KOREA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: INDONESIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: SINGAPORE DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: TAIWAN DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 48: AUSTRALIA & NEW ZEALAND DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 49: REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: REST OF WORLD DRUG DISCOVERY MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 51: LATIN AMERICA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 52: MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)